Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C14H8F4O4S |
| Molecular Weight | 348.27 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
FC1=CC=C2C(OC3=C(C=CC(OCC(F)(F)F)=C3)S2(=O)=O)=C1
InChI
InChIKey=PDIMOTRDGUQMNY-UHFFFAOYSA-N
InChI=1S/C14H8F4O4S/c15-8-1-3-12-10(5-8)22-11-6-9(21-7-14(16,17)18)2-4-13(11)23(12,19)20/h1-6H,7H2
| Molecular Formula | C14H8F4O4S |
| Molecular Weight | 348.27 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:21:13 GMT 2025
by
admin
on
Mon Mar 31 18:21:13 GMT 2025
|
| Record UNII |
O6L62LZJ0Q
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CX157
Created by
admin on Mon Mar 31 18:21:13 GMT 2025 , Edited by admin on Mon Mar 31 18:21:13 GMT 2025
|
PRIMARY | |||
|
DTXSID40174517
Created by
admin on Mon Mar 31 18:21:13 GMT 2025 , Edited by admin on Mon Mar 31 18:21:13 GMT 2025
|
PRIMARY | |||
|
205187-53-7
Created by
admin on Mon Mar 31 18:21:13 GMT 2025 , Edited by admin on Mon Mar 31 18:21:13 GMT 2025
|
PRIMARY | |||
|
18687754
Created by
admin on Mon Mar 31 18:21:13 GMT 2025 , Edited by admin on Mon Mar 31 18:21:13 GMT 2025
|
PRIMARY | |||
|
O6L62LZJ0Q
Created by
admin on Mon Mar 31 18:21:13 GMT 2025 , Edited by admin on Mon Mar 31 18:21:13 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
ACTIVE MOIETY |
Description: Reversible inhibitor of monoamine oxidase A (MAO-A) that elevates the levels of serotonin, norepinephrine and dopamine; Molecular Target: Monoamine oxidase A (MAO-A); Mechanism of Action: Monoamine oxidase (MAO) inhibitor
|